PHOENIX, Sept. 8, 2011 /PRNewswire/ -- Wolters Kluwer Pharma Solutions, a leading provider of scientific information and analytics to pharmaceutical and healthcare professionals, today announced the appointment of Henry Prolog as Vice President, Data Strategy, Acquisitions & Services. Prolog brings more than 25 years of sales, data contracts, and marketing experience in the healthcare, technology and information industries.
"Hank will help us evolve vendor relationships into true partnerships that will fulfill our customer, partner and stakeholder needs," said Michelle Woker, President & Chief Operating Officer, Healthcare Analytics, Wolters Kluwer Pharma Solutions. "This role is key to our strategy going forward, and Hank's myriad of experience will help us achieve both our short and long term goals."
Prior to joining Wolters Kluwer Pharma Solutions, Prolog held several senior management roles in related industries, including Siemens Medical, Fresenius USA, IMS Health, Verispan and US Oncology.
Most recently, Prolog was with US Oncology in Houston, where he was National Director, Channels, in charge of managing partnerships and alliances for the Informatics Division. He also spent a decade at Verispan as Regional Vice President of Sales; and was Group Director, Marketing, Service and Sales, at IMS Health in Blue Bell, Pa. He also held a Director of Sales and Marketing role at Fresenius USA in New Brunswick, N.J.; and started his illustrious healthcare information career as Manager of International Sales at Siemens Medical, Iselin, N.J., where he managed sales teams in Europe, Asia and South America.
In his new role, Prolog will manage the supply of data and information sets from PBM's, wholesalers, retail pharmacies and hospitals. He is responsible for setting data strategy for the company's healthcare analytics business. He also will determine the data agreements necessary to support top line revenue growth. Most importantly, he will continue to develop relationships with management executives from current and prospective data suppliers.
Prolog holds a B.A. from Montclair State College in Montclair, N.J. and an M.B.A. from the University of Munich in Munich, Germany. He will be based near the company's Yardley, Pa. office and will report directly to Michelle Woker, President & COO, Healthcare Analytics, in Phoenix.
For more information, visit the company's website at www.wolterskluwerpharma.com.
About Wolters Kluwer Pharma Solutions
Wolters Kluwer Pharma Solutions, Inc. (Phoenix, AZ and Yardley, PA) is a leading provider of information and analytics to the pharmaceutical, biotech, and medical device industries. The company's brands include Adis, Source® and Lippincott Williams & Wilkins. A provider of business intelligence and services, Adis publishes 19 peer-reviewed drug research journals and 2 newsletters and offers the most respected drug and clinical trials databases in the pharma industry. Lippincott Williams & Wilkins (LWW) is a leading international healthcare publisher with nearly 300 periodicals and 1,500 books in more than 100 disciplines. A longstanding provider of market data and healthcare analytics, Source® offers a unique set of comprehensive patient and physician-level prescribing and usage data. For more information, visit www.wolterskluwerpharma.com.
The company is a wholly owned subsidiary of Wolters Kluwer, U.S., part of Wolters Kluwer, a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer's leading, information-enabled tools and solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer has 2010 annual revenues of EUR3.6 billion ($4.7 billion), employs approximately 18,200 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.
SOURCE Wolters Kluwer Pharma Solutions